Clinical Trials Browser

Phase 1/2 × netrin-1 inhibitor NP137 × Clear all

NCT06150040 2025-02-20

AML-NET

Phase 1/2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04652076 2024-10-08

GYNET

Phase 1/2 Active not recruiting

Uterine Cervical Neoplasms, Endometrial Neoplasms